Effects of Sacubitril/Valsartan on biomarkers of fibrosis and inflammation in patients with heart failure with reduced ejection fraction

被引：0
|
作者：
Giovanni Battista Bolla
Antonella Fedele
Andrea Faggiano
Carla Sala
Gloria Santangelo
Stefano Carugo
机构：
[1] University of Milan and Fondazione IRCCS Ca’ GrandaOspedale Maggiore Policlinico,Department of Clinical Sciences and Community Health
[2] Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico,Cardiology Unit, Internal Medicine Department
[3] University of Milan,Division of Cardiology, Department of Health Sciences, San Paolo Hospital
来源：
BMC Cardiovascular Disorders | / 22卷
关键词：
Heart failure; Sacubitril/Valsartan; Biomarkers; Fibrosis; Left ventricular ejection fraction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction
    Butt, Jawad H.
    Dewan, Pooja
    Jhund, Pardeep S.
    Anand, Inder S.
    Atar, Dan
    Ge, Junbo
    Desai, Akshay S.
    Echeverria, Luis E.
    Kober, Lars
    Lam, Carolyn S. P.
    Maggioni, Aldo P.
    Martinez, Felipe
    Packer, Milton
    Rouleau, Jean L.
    Sim, David
    Van Veldhuisen, Dirk J.
    Vrtovec, Bojan
    Zannad, Faiez
    Zile, Michael R.
    Gong, Jianjian
    Lefkowitz, Martin P.
    Rizkala, Adel R.
    Solomon, Scott D.
    McMurray, John J., V
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (12) : 1130 - 1143
  • [32] Clinical Effectiveness of Sacubitril/Valsartan Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction
    Greene, Stephen J.
    Choi, Sujung
    Lippmann, Steven J.
    Mentz, Robert J.
    Greiner, Melissa A.
    Hardy, N. Chantelle
    Hammill, Bradley G.
    Luo, Nancy
    Samsky, Marc D.
    Heidenreich, Paul A.
    Laskey, Warren K.
    Yancy, Clyde W.
    Peterson, Pamela N.
    Curtis, Lesley H.
    Hernandez, Adrian F.
    Fonarow, Gregg C.
    O'Brien, Emily C.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (16):
  • [33] Liver function and prognosis, and influence of sacubitril/valsartan in patients with heart failure with reduced ejection fraction
    Suzuki, Kota
    Claggett, Brian
    Minamisawa, Masatoshi
    Packer, Milton
    Zile, Michael R.
    Rouleau, Jean
    Swedberg, Karl
    Lefkowitz, Martin
    Shi, Victor
    McMurray, John J., V
    Zucker, Stephen D.
    Solomon, Scott D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (09) : 1662 - 1671
  • [34] Sacubitril-valsartan treatment is associated with decrease in central apneas in patients with heart failure with reduced ejection fraction
    Passino, Claudio
    Sciarrone, Paolo
    Vergaro, Giuseppe
    Borrelli, Chiara
    Spiesshoefer, Jens
    Gentile, Francesco
    Emdin, Michele
    Giannoni, Alberto
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 330 : 112 - 119
  • [35] Sacubitril/valsartan versus angiotensin inhibitors and arrhythmia endpoints in heart failure with reduced ejection fraction
    Fernandes, Amanda D. F.
    Fernandes, Gilson C.
    Ternes, Caique M. P.
    Cardoso, Rhanderson
    Chaparro, Sandra V.
    Goldberger, Jeffrey J.
    HEART RHYTHM O2, 2021, 2 (06): : 724 - 732
  • [36] Effect of sacubitril valsartan on cardiac function and endothelial function in patients with chronic heart failure with reduced ejection fraction
    Li, Bao-Hua
    Fang, Kuai-Fa
    Lin, Pei-Huan
    Zhang, Yi-Hui
    Huang, Yong-Xiang
    Jie, Hai
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2021, 77 (04) : 425 - 433
  • [37] Cost-Effectiveness of Switching Patients With Heart Failure and Reduced Ejection Fraction to Sacubitril/Valsartan: The Australian Perspective
    Chin, Ken Lee
    Zomer, Ella
    Wang, Bing H.
    Liew, Danny
    HEART LUNG AND CIRCULATION, 2020, 29 (09) : 1310 - 1317
  • [38] Sacubitril/valsartan: preliminary experience in post-acute stabilized patients with reduced ejection fraction heart failure
    Parisi, Cristian
    De Giusti, Marco
    Castello, Lorenzo
    Dito, Eleonora
    Proietti, Fabrizio
    Tomai, Fabrizio
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 : 17 - 20
  • [39] Sacubitril/valsartan improves both functional and echocardiographic parameters in patients with chronic heart failure with reduced ejection fraction
    Cosentino, Eugenio Roberto
    Degli Esposti, Daniela
    Miceli, Rinaldo
    Bentivenga, Crescenzio
    Landolfo, Matteo
    Cicero, Arrigo F. G.
    Berardi, Emanuela
    Spinardi, Luca
    Magri, Gianluigi
    Dugato, Vittorio
    Borghi, Claudio
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 : 9 - 12
  • [40] Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction Rationale and Design of the LIFE Trial
    Mann, Douglas L.
    Greene, Stephen J.
    Givertz, Michael M.
    Vader, Justin M.
    Starling, Randall C.
    Ambrosy, Andrew P.
    Shah, Palak
    McNulty, Steven E.
    Mahr, Claudius
    Gupta, Divya
    Redfield, Margaret M.
    Lala, Anuradha
    Lewis, Gregory D.
    Mohammed, Selma F.
    Gilotra, Nisha A.
    DeVore, Adam D.
    Gorodeski, Eiran Z.
    Desvigne-Nickens, Patrice
    Hernandez, Adrian F.
    Braunwald, Eugene
    JACC-HEART FAILURE, 2020, 8 (10) : 789 - 799
12345